ISAF Hybrid 2023 Back

05 - 07 October 2023 Rome, Italy

David Denning

United Kingdom

David Denning

Dr David Denning is Professor of Infectious Diseases and Global Health at The University of Manchester having practiced as an infectious diseases clinician, with a special interest in fungal disease, for 40 years.  He serves as the Chief Executive of Global Action For Fungal Infections (GAFFI). GAFFI (www.GAFFI.org) advocates for universal access to fungal diagnostics and antifungal therapies. Dr Denning managed the UK’s National Aspergillosis Centre, Manchester from 2009-2020. He has published extensively (>700 academic papers) and has a citation H-index of 126.  He has been the managing editor of the Aspergillus Website since 1998 (www.Aspergillus.org.uk). He leads LIFE (Leading International Fungal Education (http://fungaleducation.org/), which is focused on improving patient outcomes through online education. He has contributed to multiple guidelines for the diagnosis and treatment of serious fungal diseases.


Sessions

Thursday 5 Oct
18:00 - 18:30 Fungi and antimicotic therapy Symposium Sala Italia
Friday 6 Oct
16:00 - 17:30 The influence of the exposome Plenary (streamed) Auditorium , Channel 1